Moreover, EZH2 is able to directly interact with β-catenin and ERα in a PRC2-independent manner to activate cyclin D1 and c-Myc expression upon estrogen stimulation to induce the proliferation of breast cancer cells (Figure 5D) [256]. This evidence concerns the gene EZH2 and breast carcinoma.